GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regent Pacific Group Ltd (OTCPK:RPGLF) » Definitions » Price-to-Owner-Earnings

RPGLF (Regent Pacific Group) Price-to-Owner-Earnings : (As of May. 18, 2025)


View and export this data going back to . Start your Free Trial

What is Regent Pacific Group Price-to-Owner-Earnings?

As of today (2025-05-18), Regent Pacific Group's share price is $0.0007. Regent Pacific Group does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Regent Pacific Group's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Regent Pacific Group was 6.07. The lowest was 1.87. And the median was 3.18.


RPGLF's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.33
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-18), Regent Pacific Group's share price is $0.0007. Regent Pacific Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.02. Therefore, Regent Pacific Group's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-18), Regent Pacific Group's share price is $0.0007. Regent Pacific Group's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.02. Therefore, Regent Pacific Group's PE Ratio without NRI for today is At Loss.

During the past 13 years, Regent Pacific Group's highest PE Ratio without NRI was 24.23. The lowest was 0.00. And the median was 12.12.


Regent Pacific Group Price-to-Owner-Earnings Historical Data

The historical data trend for Regent Pacific Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regent Pacific Group Price-to-Owner-Earnings Chart

Regent Pacific Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3.75 - - -

Regent Pacific Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regent Pacific Group's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regent Pacific Group's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Price-to-Owner-Earnings falls into.


;
;

Regent Pacific Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Regent Pacific Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0007/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regent Pacific Group  (OTCPK:RPGLF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Regent Pacific Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Regent Pacific Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Regent Pacific Group Business Description

Traded in Other Exchanges
Address
5 Queen's Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Its geographical segments are China, Europe, Hong Kong, and Taiwan.

Regent Pacific Group Headlines

No Headlines